HeartCare Medical-B (06609): Registration Application for Self-Expanding Intracranial Drug-Eluting Stent Accepted by NMPA

HeartCare (06609) announced that the registration application for its self-expanding intracranial drug-eluting stent, developed by the group, has been accepted by the National Medical Products Administration (NMPA) of China.

Self-expanding Intracranial Drug-eluting Stents for the Treatment of Intracranial Atherosclerotic Stenosis: These stents provide support and reopening for narrowed and obstructed lumens and effectively prevent in-stent lumen restenosis. According to publicly available information, there are currently no similar products approved for marketing globally, and our company’s R&D progress for this type of product is at a leading level within the industry.